| Financial Year |
March 31 2023 |
| Monetary Funds |
340,592,596.07 |
| Held-for-trading Financial Assets |
130,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
93,525,675.56 |
| Advances to Suppliers |
10,885,538.19 |
| Other Receivables |
23,837,710.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
159,832,819.20 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,023,027.81 |
| Total Current Assets |
780,355,872.01 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
25,149,243.94 |
| Investment Properties |
-- |
| Fixed Assetes |
205,151,207.60 |
| Under-construction Projects |
93,589,918.81 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
36,093,408.49 |
| R&D expenses |
13,041,266.76 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,297,045.75 |
| Deferred Income Tax Assets |
3,797,344.59 |
| Other Non-Current Assets |
63,341,808.85 |
| Sub-Total of Non-Current Assets |
475,893,741.61 |
| Total Assets |
1,256,249,613.62 |
| Short-Term Loans |
50,647,697.23 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
21,784,964.42 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,231,054.92 |
| Taxes Payable |
8,379,367.76 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
108,562,270.02 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
764,166.14 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
228,711,370.64 |
| Long-term Loans |
179,186,416.42 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,039,352.50 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
186,734,483.23 |
| Total Liabilities |
415,445,853.87 |
| Paid-In Capital(Or Share Stock) |
80,000,000.00 |
| Capital Surplus |
408,398,233.41 |
| Surplus Reserve |
6,549,269.62 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
345,856,256.72 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
840,803,759.75 |
| Owner's Equity（Stockholder's Equity） |
840,803,759.75 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,256,249,613.62 |
